Omeros (OMER) Operating Leases (2018 - 2026)
Omeros recorded quarterly Operating Leases of $5.6 million in Q1 2026, down 22.75% quarter-over-quarter from $7.2 million in Q4 2025, and down 53.13% year-over-year from $11.9 million in Q1 2025.
Omeros' Operating Leases history runs 9 years deep, the most recent figure standing at $5.6 million for Q1 2026.
- In Q1 2026, Operating Leases fell 53.13% year-over-year to $5.6 million; the TTM figure through Mar 2026 stood at $5.6 million (down 53.13% YoY), while the FY2025 annual figure was $7.2 million, down 46.2% from the prior year.
- Operating Leases came in at $5.6 million for Q1 2026 at Omeros, down from $7.2 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $24.5 million in Q2 2022 to a low of $5.6 million in Q1 2026.
- A 5-year average of $16.4 million and a median of $16.8 million in 2024 frame the typical range for Operating Leases.
- Across the five-year window, Operating Leases slipped 12.38% in 2023 and tumbled 53.13% in 2026, its largest moves.
- Omeros' Operating Leases stood at $22.4 million in 2022, then decreased by 19.1% to $18.1 million in 2023, then declined by 25.78% to $13.5 million in 2024, then sank by 46.2% to $7.2 million in 2025, then slipped by 22.75% to $5.6 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $5.6 million, $7.2 million, and $8.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.60 Mn |
| Dec 31, 2025 | 7.25 Mn |
| Sep 30, 2025 | 8.84 Mn |
| Jun 30, 2025 | 10.38 Mn |
| Mar 31, 2025 | 11.94 Mn |
| Dec 31, 2024 | 13.47 Mn |
| Sep 30, 2024 | 14.24 Mn |
| Jun 30, 2024 | 15.63 Mn |
| Mar 31, 2024 | 16.75 Mn |
| Dec 31, 2023 | 18.14 Mn |
| Sep 30, 2023 | 19.25 Mn |
| Jun 30, 2023 | 20.42 Mn |
| Mar 31, 2023 | 21.29 Mn |
| Dec 31, 2022 | 22.43 Mn |
| Sep 30, 2022 | 23.53 Mn |
| Jun 30, 2022 | 24.52 Mn |
| Mar 31, 2022 | 24.30 Mn |
| Dec 31, 2021 | 34.38 Mn |
| Sep 30, 2021 | 30.29 Mn |
| Jun 30, 2021 | 31.41 Mn |
| Mar 31, 2021 | 27.81 Mn |
| Dec 31, 2020 | 28.77 Mn |
| Sep 30, 2020 | 33.47 Mn |
| Jun 30, 2020 | 34.24 Mn |
| Mar 31, 2020 | 34.99 Mn |
| Dec 31, 2019 | 32.32 Mn |
| Sep 30, 2019 | 31.71 Mn |
| Jun 30, 2019 | 25.95 Mn |
| Mar 31, 2019 | 26.58 Mn |
| Dec 31, 2018 | 1.58 Mn |